Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Hung

Showing results (231-240 of 563) with videos related to

Pageof 57
Sort By:
Journal of Gastroenterology and Hepatology|February 22, 2011
Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patientsChien-Hung Chen, Chuan-Mo Lee, Chao-Hung Hung, et al.
Hepatology International|July 24, 2015
Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversionChien-Hung Chen, Chuan-Mo Lee, Jing-Houng Wang, et al.
Hepatology (Baltimore, Md.)|August 14, 2012
Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent areaChao-Hung Hung, Kuo-Chin Chang, Sheng-Nan Lu, et al.
Cell Biology International|February 2, 2006
A novel terminal differentiation model of human articular chondrocytes in three-dimensional cultures mimicking chondrocytic changes in osteoarthritisMei-Ling Ho, Je-Ken Chang, Shun-Cheng Wu, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2022
Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessationTzu-Ning Tseng, Wen-Juei Jeng, Tsung-Hui Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 15, 2013
Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patientsHsin-Ming Wang, Chao-Hung Hung, Sheng-Nan Lu, et al.
American Journal of Cancer Research|December 9, 2020
Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective studyChien-Hung Chen, Chi-Yi Chen, Jing-Houng Wang, et al.
The American Journal of Hospice & Palliative Care|June 19, 2014
Wishes of Patients With Terminal Cancer and Influencing Factors Toward the Use of Antibiotics in TaiwanChien-An Yao, Meng-Yun Hsieh, Tai-Yuan Chiu, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2018
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovirMing-Te Kuo, Tsung-Hui Hu, Chao-Hung Hung, et al.
Analytical Chemistry|March 15, 2024
PS<sup>2</sup>MS: A Deep Learning-Based Prediction System for Identifying New Psychoactive Substances Using Mass SpectrometryYi-Ching Lin, Wei-Chen Chien, Yu-Xuan Wang, et al.
Pageof 57

Showing results (231-240 of 563) with videos related to

Sort By:
Pageof 57
Journal of Gastroenterology and Hepatology|February 22, 2011
Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patientsChien-Hung Chen, Chuan-Mo Lee, Chao-Hung Hung, et al.
Hepatology International|July 24, 2015
Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversionChien-Hung Chen, Chuan-Mo Lee, Jing-Houng Wang, et al.
Hepatology (Baltimore, Md.)|August 14, 2012
Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent areaChao-Hung Hung, Kuo-Chin Chang, Sheng-Nan Lu, et al.
Cell Biology International|February 2, 2006
A novel terminal differentiation model of human articular chondrocytes in three-dimensional cultures mimicking chondrocytic changes in osteoarthritisMei-Ling Ho, Je-Ken Chang, Shun-Cheng Wu, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2022
Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessationTzu-Ning Tseng, Wen-Juei Jeng, Tsung-Hui Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 15, 2013
Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patientsHsin-Ming Wang, Chao-Hung Hung, Sheng-Nan Lu, et al.
American Journal of Cancer Research|December 9, 2020
Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective studyChien-Hung Chen, Chi-Yi Chen, Jing-Houng Wang, et al.
The American Journal of Hospice & Palliative Care|June 19, 2014
Wishes of Patients With Terminal Cancer and Influencing Factors Toward the Use of Antibiotics in TaiwanChien-An Yao, Meng-Yun Hsieh, Tai-Yuan Chiu, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2018
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovirMing-Te Kuo, Tsung-Hui Hu, Chao-Hung Hung, et al.
Analytical Chemistry|March 15, 2024
PS<sup>2</sup>MS: A Deep Learning-Based Prediction System for Identifying New Psychoactive Substances Using Mass SpectrometryYi-Ching Lin, Wei-Chen Chien, Yu-Xuan Wang, et al.
Pageof 57